Chief Medical Officer of Kymera Therapeutics, Inc. (NASDAQ:KYMR), Gollob Jared, sells 7,550 shares worth $440,836
According to Kymera Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 19 07:27 PM, company Chief Medical Officer, Gollob Jared disclosed selling 7,550 shares at a cost of $58.39. At the time of this transaction (Feb 17), this trade was worth $440,836 in total. As of Feb 17, Gollob Jared now owns 99,997 shares in total worth about $5,467,835.96.
For the last few recent trades made by Kymera Therapeutics, Inc. (NASDAQ:KYMR) Chief Medical Officer, Gollob Jared, we have the following information:
- SEC Form 4 filing: Feb 18: Sold 6,499 shares at the rate of $55.94 per share. Total worth of this trade was $363,540. Total number of shares owned as of Feb 18 were 93,498
- SEC Form 4 filing: Feb 19: Sold 8,887 shares at the rate of $55.09 per share. Total worth of this trade was $489,559. Total number of shares owned as of Feb 19 were 84,611
Posted by
George Daniels
on Saturday February 20 2021, 7:26 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
